Approval · Notice of Compliance 29586 · 2022
NGENLA: Notice of Compliance 29586
Issued November 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29586
- Date
- November 28, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Drug substance manufacturing process change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NGENLA | Not yet assigned | — |
Medicinal ingredients
- SOMATROGON 20 MG per ML
- SOMATROGON 50 MG per ML